🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main objective of this trial is to evaluate the safety, reactogenicity,...
Status
Recruiting
Location
Diex Recherche Quebec
Start Date
2026-08-11
Trial ID
NCT07764237
Treatments Being Tested
The main purpose of this study is to evaluate the safety and immunogenicity...
Status
Completed
Location
CenExcel RCA
Start Date
2022-09-21
Trial ID
NCT05664334
The primary purpose of this study is to assess the immunogenicity and safet...
Status
Completed
Location
Icosavax Investigational Site US022
Start Date
2024-06-10
Trial ID
NCT06481579
Treatments Being Tested
The purpose of this study is to assess the safety and immunogenicity of mRN...
Status
Active Not Recruiting
Location
Matrix Clinical Research
Start Date
2023-02-15
Trial ID
NCT05743881
This study is a Phase 1/2, randomized, observer-blind, active and placebo-c...
Status
Recruiting
Location
Hawthorne Health - Gadsden City Pharmacy- Site Number : 8400025
Start Date
2026-07-22
Trial ID
NCT07734649
Treatments Being Tested
This phase 1/2 study will evaluate the safety, reactogenicity and immunogen...
Status
Active Not Recruiting
Location
Fusion Clinical Research
Start Date
2025-06-18
Trial ID
NCT06984094
Treatments Being Tested
The aim of this study is to evaluate the safety, reactogenicity, and immune...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2026-06-05
Trial ID
NCT07628049
Treatments Being Tested
The objective of this study is to evaluate the safety and immunogenicity of...
Status
Completed
Location
Paratus Clinical
Start Date
2025-03-19
Trial ID
NCT06850051
Treatments Being Tested
The primary purpose of the study is to assess the safety, tolerability and ...
Status
Completed
Location
AMR Phoenix
Start Date
2023-05-15
Trial ID
NCT05903183
The purpose of this study is to evaluate the safety and immunogenicity an i...
Status
Completed
Location
Velocity Gardena Site Number : 8400011
Start Date
2024-01-23
Trial ID
NCT06237296
Treatments Being Tested